Literature DB >> 1314720

Advanced glycosylation end products in the mesenteric artery.

E MacDonald1, W K Lee, S Hepburn, J Bell, P J Scott, M H Dominiczak.   

Abstract

We measured advanced glycosylation end products in the mesenteric artery of 37 patients (ages 29-82 years), 34 of whom were nondiabetic. Samples of arterial tissue were obtained during bowel resectioning. Advanced glycosylation end products were measured as collagen-linked fluorescence (excitation wavelength 370 nm, emission wavelength 440 nm) after collagenase digestion of tissue samples. Mean fluorescence of the arterial samples was 15 U/mg (range 5.3-27). Collagen fluorescence correlated with patients' age (r = 0.57; P less than 0.001). No difference in the collagen-linked fluorescence was observed between men and women (P = 0.63), hypertensive and normotensive patients (P = 0.44), smokers and nonsmokers (P = -0.52), and patients with and without symptomatic coronary heart disease (P = 0.7). This study demonstrates, for the first time, the relationship between collagen-linked fluorescence and patients' age in human arterial tissue ex vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314720

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  2 in total

1.  Breakers of advanced glycation end products restore large artery properties in experimental diabetes.

Authors:  B H Wolffenbuttel; C M Boulanger; F R Crijns; M S Huijberts; P Poitevin; G N Swennen; S Vasan; J J Egan; P Ulrich; A Cerami; B I Lévy
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

2.  Age-dependent accumulation of advanced glycation endproducts is accelerated in combined hyperlipidemia and hyperglycemia, a process attenuated by L-arginine.

Authors:  A Georgescu; D Popov
Journal:  J Am Aging Assoc       Date:  2000-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.